
Client References
The high quality of the consulting services provided by GAEU is confirmed by a long reference list of companies and institutions that have taken advantage of EU grants and other public subsidies to minimize risks involved in their projects and investments.
We have assisted European clients from different areas of industry to obtain funding to research and development projects (R&D projects), investments in new technologies, staff training projects, implementation of renewable energy sources and international business development.

AlzeCure Pharma: €2.5m

PharmNovo: €17.5m

BrainCool AB (publ): €12.5m

Compular: €5.3m

Qlucore AB (publ): €2.5m

Multi4: €75k

Inossia: €7.3m

Ligna Energy: €630k

EmbeDL: €2.5m

Cyto365: €3.9m

Seatwirl AB (publ): €5m

Lindhe Xtend: €3.6m

Genagon: €500k

Cellevate: €5.48m (in total)

Elicera Therapeutics AB (publ): €2.5m

Minalyze: €4m

Greeniron: €1.7m

IRRAS AB (publ): €10m

Scandinavian Realheart AB (publ): €500k

Pulpac: €1m

Vicore Pharma AB (publ): €1.7m

Clinical Laserthermia Systems AB (publ): €2.1m

Cellink (BICO Group) AB (publ): €2.5m

Colzyx: €5.5m (in total)

Immunovia AB (publ): €4.25m

Climate Recovery: €1.7m

Multi4: €500k

JonDeTech AB (publ): €500k

Betagenon: €1.8m

Cinnober AB (publ): €2.5m

CombiGene AB (publ): €3.3m

SenzaGen AB (publ): €2.4m

Corline Biomedical AB (publ): €2.3m

Ilya Pharma: €3.0m

Klaria AB (publ): €2.0m

Idogen AB (publ): €2.9m

Scandinavian Biopharma: €3.0m

Targeted Immunotherapies: €2.7m

Verigraft: €2.2m

CytaCoat

Gradientech

Pila Pharma

Surgical Science: 2.5m SEK

Ellen: 1.5m SEK

Aerocrine: 1.5m SEK

Nelson Garden: €1.2m

Opsis: €2.3m

Cellcomb: €190k

Nord West Yacht: 1.7m SEK

Huhnseal: 1.95m SEK

Prismatic Sensors: €2.4m

MSE Omnifinity: €220k

Upstream: €100k

Avionero

Minut

Adverty

Cognibotics

Windak
